Clinical Trials on Alzheimer’s Disease (CTAD) Conference :: ProMIS Neurosciences, Inc. (PMN)

Third Quarter 2026 Earnings Conference Call Click Here

To view our PMN310 Scientific and Clinical Update (November 2026) Click Here

Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Poster presentation: Monday, Nov 16-Tues Nov 17th

Poster title: Poster # P047, Interim Safety and Biomarker Analysis of PRECISE-AD*